Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes

Launched by UNC LINEBERGER COMPREHENSIVE CANCER CENTER · Jul 10, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a program called enCompass Humana, designed to support family members who care for adults with both cancer and diabetes. Caring for someone with these conditions can be very challenging, and many caregivers don’t get the help they need. This program offers coaching and guidance to help caregivers find resources, manage stress, and feel more confident in their role. The study aims to see if this support is practical, well-received, and helpful in reducing caregiver stress and improving their ability to cope, as well as potentially lowering anxiety and depression in the patients they care for.

To join the study, caregivers must be adults who speak English and are caring for someone with stage II-IV cancer and diabetes who is actively receiving cancer treatment. Both the caregiver and the patient need to agree to participate. Participants will be part of a program that provides personalized coaching and help navigating available services. The goal is to make it easier for caregivers to get the support they need, especially those who might not have access to many resources. This study is currently recruiting volunteers who want to help improve support for caregivers like themselves.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Inclusion Criteria for Caregivers
• • English-speaking.
• • Ability to provide written or verbal informed consent to participate in the study;
• • Willing and able to comply with study procedures based on the judgment of the investigator or protocol designee;
• • Be at least 18 years of age at the time of consent; and
• • Identify as an informal (unpaid) caregiver for an adult with a stage II-IV cancer AND diabetes.
• • Inclusion Criteria for patients
• • English-speaking
• • Ability to provide informed consent.
• • Be at least 18 years of age at the time of consent; and
• • Their identified caregiver is enrolled in the study
• • Diagnoses: (must have cancer and diabetes)
• • Have a cancer diagnosis for which they are being actively treated at one of the study sites
• • Have a cancer diagnosis, stage II-IV solid tumor or any hematologic malignancy
• • Receiving active cancer treatment s, not including hormonal therapy
• • Concurrent history of diabetes with need for ongoing management
• Exclusion Criteria:
• • Exclusion Criteria for Caregivers
• • Unable to complete self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;
• • Existence of another co-morbid disease other than diabetes, which in the opinion of the investigator, prohibits participation in the protocol;
• • Participation in the intervention development phase of this intervention
• • Exclusion Criteria for patients
• • Self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;
• • Existence of other co-morbid disease, which in the opinion of the investigator, prohibits participation in the protocol;
• • Their caregiver does not enroll in the study or withdraws consent